Skip to content

Pre experiment on the immune function of medical staff after COVID-19 infection and the intervention effect of "Sangshu Yangzheng Decoction"

Pre experiment on the immune function of medical staff after COVID-19 infection and the intervention effect of "Sangshu Yangzheng Decoction"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000372
Enrollment
Unknown
Registered
2024-09-04
Start date
2023-07-26
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune function after COVID-19 infection

Interventions

control group:Nil
Treatment group:Sangzhu Yangzheng Decoction was given orally for 14 days, soaked in boiled water, 200ml each time, soaked 3 times a day, a total of 600 ml

Sponsors

Yanqing hospital, Beijing traditional Chinese medicine hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Confirmed history of SARS-CoV-2 infection from December 7 to December 31, 2022. (2) Age 18 to 65 years old; (3) Voluntarily sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those with severe diseases such as heart, liver, kidney, immune system, and hematopoietic system. (2) Individuals with a history of severe emotional disorders or mental illness or a family history of mental illness; (3) Pregnant or lactating women. (4) Due to allergies and other reasons, patients cannot be treated with traditional Chinese medicine prescriptions. (5) Patients with acute COVID-19 infection (re infected with COVID-19 within 2 weeks). (6) After COVID-19 infection, severe fatigue, cough, chest tightness, palpitations, abdominal pain, nausea, dizziness and other COVID-19 complications or sequelae occur, and drug treatment intervention is required. (7) Participated in other clinical trials within one month.

Design outcomes

Primary

MeasureTime frame
Detection of Treg and Th1, Th2 and Th17;Analysis of TBNK lymphocyte subpopulations;

Secondary

MeasureTime frame
IgG;IgM antibody to novel coronavirus;IgG antibody to novel coronavirus;IgM;IgA;Upper respiratory tract flora;

Countries

China

Contacts

Public ContactQingquan Liu

Beijing Hospital of Traditional Chinese Medicine

liuqingquan2003@126.com+86 10 5217 6965

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026